Robert F. Kennedy Jr.'s long record of questioning the safety of childhood vaccinations persisted as a flash point for him Thursday during a confirmation hearing where a key Republican quickly raised concerns about his views.
Senate Democrats grilled Robert F. Kennedy Jr. over his various controversial statements including his stance on vaccines during his confirmation hearing to be President Donald Trump’s health and human services secretary,
Mr. Kennedy appears to have most Republicans behind him as he seeks the job of health secretary, though he couldn’t escape his past stances on vaccines and abortion.
RFK Jr. is back on the Hill for a second day of testimony, this time before a different Senate committee, after a first round that was contentious but saw no GOP defections.
Several of Donald Trump’s picks for his Cabinet and key roles in his administration are facing confirmation hearings in the Senate today as the president continues to implement executive actions to transform the government.
The Senate Finance Committee confirmation hearing of Robert F. Kennedy, Jr., President Donald Trump's Health and Human Services secretary nominee, turns heated as Democrats grill him over vaccines
Robert F. Kennedy Jr. will emphasize that he is not “anti-vaccine” when he appears Wednesday in Congress at the first of two straight days of Senate confirmation hearings.
An advocacy group founded by former Vice President Mike Pence is escalating its fight against Robert F. Kennedy Jr., this time with an ad that uses President Trump’s past criticisms of Kennedy to
Several of Donald Trump’s Cabinet picks, including Health and Human Services secretary nominee Robert F. Kennedy Jr., will face confirmation hearings today as the president continues to forge ahead with his agenda.
Buried under layers of secrecy and red tape, the full findings related to the homicides of President John F. Kennedy, his brother and Senator Robert F. Kennedy, and the Reverend Dr. Martin Luther King Jr.
Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, told U.S. senators during his confirmation hearing on Wednesday that he would finalize regulations aimed at increasing the participation of diverse patient populations in clinical trials.